Welcome post-doc Xueyan Hu to join our Group!!!

2022-2-15

In cooperation with Professor Weili Zhao, Our paper on "Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells" is accepted for publication in Signal Transduction and Targeted Therapy! Congratulations to all the coauthors!

 

2022-1-18

 

DOI: 10.1038/s41392-022-00895-2

 

Congrats to Meng Cheng and Tao leng for passing dissertation defense and achieving the master degree!

 

2022-1-13